Phase I trial investigating the pharmacokinetics of onapristone in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2015
Price : $35 *
At a glance
- Drugs Onapristone (Primary)
- Indications Breast cancer; Endometrial cancer
- Focus Pharmacokinetics
- 10 Sep 2015 Results published in the Cancer Chemotherapy and Pharmacology.
- 21 Aug 2013 Status changed from not yet recruiting to recruiting, according to an Arno Therapeutics media release. The initiation follows Investigational Medicinal Product Dossier (IMPD) approval by French Health Authority ANSM in late July 2013.
- 10 Apr 2013 This trial is expected to start in the second half of 2013, according to an Arno Therapeutics media release.